Cargando…

Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust

BACKGROUND: Hypoglycaemia is a common and potentially life-threatening condition in people with diabetes, commonly caused by medications such as insulin. Hypoglycaemic events often require in-patient treatment and/or follow-up with a diabetes specialist nurse (DSN) or GP to make adjustments to medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Andrew, Dallosso, Helen, Gray, Laura, James, June, Taylor, Cat, Davies, Melanie, Shaw, Debbie, Siriwardena, Niroshan, Khunti, Kamlesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The College of Paramedics 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892445/
https://www.ncbi.nlm.nih.gov/pubmed/35340578
http://dx.doi.org/10.29045/14784726.2022.03.6.4.3
_version_ 1784662169919422464
author Willis, Andrew
Dallosso, Helen
Gray, Laura
James, June
Taylor, Cat
Davies, Melanie
Shaw, Debbie
Siriwardena, Niroshan
Khunti, Kamlesh
author_facet Willis, Andrew
Dallosso, Helen
Gray, Laura
James, June
Taylor, Cat
Davies, Melanie
Shaw, Debbie
Siriwardena, Niroshan
Khunti, Kamlesh
author_sort Willis, Andrew
collection PubMed
description BACKGROUND: Hypoglycaemia is a common and potentially life-threatening condition in people with diabetes, commonly caused by medications such as insulin. Hypoglycaemic events often require in-patient treatment and/or follow-up with a diabetes specialist nurse (DSN) or GP to make adjustments to medication. This referral pathway commonly relies on patient self-referral to primary care, and as a result many patients are not actively followed up and go on to experience repeat hypoglycaemic events. METHODS: Randomised controlled trial in partnership with East Midlands Ambulance Service NHS Trust. People with diabetes calling out an ambulance for a severe hypoglycaemic episode and meeting the eligibility criteria were randomised to either a novel DSN-led pathway or to their general practice for routine follow-up. Primary outcome was proportion of participants with a documented consultation with a healthcare professional to discuss the management of their diabetes within 28 days of call-out. RESULTS: 162 people were randomised to one of the pathways (73 DSN arm, 89 GP arm) with 81 (50%, 35 DSN, 46 GP) providing full consent to be followed up. Due to lower than anticipated randomisation and consent rates, the recruitment target was not met. In the 81 participants who provided full consent, there were higher rates of consultation following the call-out when referred to a DSN compared to primary care (90% vs. 65%). Of the 81 participants, 26 (32%) had a second call-out within 12 months. CONCLUSIONS: Consultation rates following the call-out were high in the DSN-led arm, but there was insufficient power to complete the planned comparative analysis. The study highlighted the difficulty in recruitment and delivery of research in pre-hospital emergency care. Further work is needed to provide more feasible study designs and consent procedures balancing demands on ambulance staff time with the need for robust well-designed evaluation of referral pathways.
format Online
Article
Text
id pubmed-8892445
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The College of Paramedics
record_format MEDLINE/PubMed
spelling pubmed-88924452023-03-01 Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust Willis, Andrew Dallosso, Helen Gray, Laura James, June Taylor, Cat Davies, Melanie Shaw, Debbie Siriwardena, Niroshan Khunti, Kamlesh Br Paramed J Original Research BACKGROUND: Hypoglycaemia is a common and potentially life-threatening condition in people with diabetes, commonly caused by medications such as insulin. Hypoglycaemic events often require in-patient treatment and/or follow-up with a diabetes specialist nurse (DSN) or GP to make adjustments to medication. This referral pathway commonly relies on patient self-referral to primary care, and as a result many patients are not actively followed up and go on to experience repeat hypoglycaemic events. METHODS: Randomised controlled trial in partnership with East Midlands Ambulance Service NHS Trust. People with diabetes calling out an ambulance for a severe hypoglycaemic episode and meeting the eligibility criteria were randomised to either a novel DSN-led pathway or to their general practice for routine follow-up. Primary outcome was proportion of participants with a documented consultation with a healthcare professional to discuss the management of their diabetes within 28 days of call-out. RESULTS: 162 people were randomised to one of the pathways (73 DSN arm, 89 GP arm) with 81 (50%, 35 DSN, 46 GP) providing full consent to be followed up. Due to lower than anticipated randomisation and consent rates, the recruitment target was not met. In the 81 participants who provided full consent, there were higher rates of consultation following the call-out when referred to a DSN compared to primary care (90% vs. 65%). Of the 81 participants, 26 (32%) had a second call-out within 12 months. CONCLUSIONS: Consultation rates following the call-out were high in the DSN-led arm, but there was insufficient power to complete the planned comparative analysis. The study highlighted the difficulty in recruitment and delivery of research in pre-hospital emergency care. Further work is needed to provide more feasible study designs and consent procedures balancing demands on ambulance staff time with the need for robust well-designed evaluation of referral pathways. The College of Paramedics 2022-03-01 2022-03-01 /pmc/articles/PMC8892445/ /pubmed/35340578 http://dx.doi.org/10.29045/14784726.2022.03.6.4.3 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Willis, Andrew
Dallosso, Helen
Gray, Laura
James, June
Taylor, Cat
Davies, Melanie
Shaw, Debbie
Siriwardena, Niroshan
Khunti, Kamlesh
Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
title Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
title_full Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
title_fullStr Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
title_full_unstemmed Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
title_short Randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
title_sort randomised controlled trial of an innovative hypoglycaemia pathway for self-care at home and admission avoidance: a partnership approach with a regional ambulance trust
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892445/
https://www.ncbi.nlm.nih.gov/pubmed/35340578
http://dx.doi.org/10.29045/14784726.2022.03.6.4.3
work_keys_str_mv AT willisandrew randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT dallossohelen randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT graylaura randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT jamesjune randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT taylorcat randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT daviesmelanie randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT shawdebbie randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT siriwardenaniroshan randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust
AT khuntikamlesh randomisedcontrolledtrialofaninnovativehypoglycaemiapathwayforselfcareathomeandadmissionavoidanceapartnershipapproachwitharegionalambulancetrust